跳至主要内容
临床试验/NCT02401360
NCT02401360已完成不适用

A Controlled Study to Assess Clinical Gingivitis and Microbiome Following the Use of Multiple Oral Hygiene Products

Procter and Gamble0 个研究点目标入组 106 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
106
主要终点
Gingivitis

研究概览

简要总结

This study assessed the efficacy of an oral hygiene regimen relative to a standard marketed toothpaste and manual toothbrush.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •give written informed consent prior to their participation;
  • •be 18 to 65 years of age at the time of enrollment;
  • •agree not to participate in any other oral/dental product studies;
  • •agree to delay any elective dentistry (including a dental prophylaxis);
  • •agree to refrain from the use of any non-study oral care products (including floss and mouthrinse) during the course of the study;
  • •agree to return for the scheduled visits and follow study procedures;
  • •be in good general health as determined by the investigator/designee based on a review of the health history/update for participation in the study;
  • •have more than 10 bleeding sites at visits 1-3
  • •Consistency of bleeding site number at baseline may be considered;
  • •have a minimum of 18 natural teeth with facial and lingual scorable surfaces; and
  • •refrain from performing any oral hygiene or consuming anything by mouth (except a small amount of water) at least 4 hours prior to their appointment.

排除标准

  • •teeth that are grossly carious, fully crowned, extensively restored and have heavy dental calculus
  • •antibiotic, anti-inflammatory or anti-coagulant therapy within two weeks of to the baseline exam
  • •medical conditions that the investigator considers significant and that may compromise the evaluation of study results
  • •currently participating in any other clinical trial
  • •participated in a clinical trial for plaque/gingivitis within the previous 30 days
  • •pregnant or lactating
  • •orthodontic appliances or removable partial dentures
  • •soft or hard tissue tumor of the oral cavity
  • •advanced periodontal disease
  • •history of hepatitis, diabetes, or other communicable diseases
  • •history of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
  • •history of significant adverse effects following the use of oral hygiene products such as toothpaste
  • •oral pathoses that could interfere with compliance and/or examinations or that need treatment.

研究组 & 干预措施

Experimental Group

Experimental

Oral care regimen

干预措施: China Crest® Pro-health 7 Complete Toothpaste (Drug)

Control Group

Placebo Comparator

Toothbrush and toothpaste

干预措施: China Crest® Cavity Protection Toothpaste (Drug)

结局指标

主要结局

Gingivitis

时间窗: Day 24

Gingivitis was assessed according to the Gingival Bleeding Index

次要结局

  • Plaque Examination(Day 24)

研究者

发起方
Procter and Gamble
申办方类型
Industry
责任方
Sponsor

相似试验